“Dexcom is raising fiscal year 2026 guidance for Non-GAAP Operating Margin and Adjusted EBITDA Margin, and reiterating guidance for Revenue and Non-GAAP Gross Profit Margin at the following levels: • Revenue of $5.16 - $5.25 billion (approximately 11-13% growth) • Non-GAAP Gross Profit Margin of approximately 63-64% • Non-GAAP Operating Margin of approximately 23-23.5% • Adjusted EBITDA Margin of approximately 31-31.5%”
Earnings Releases
DEXCOM INC reported quarter ended March 31, 2026 results: revenue $1.192 billion, net income $199.5 million, EPS $0.51.
“(Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights: • Revenue grew 15% year-over-year to $1.192 billion on a reported basis and 12% year-over-year on an organic 1 basis. • U.S. revenue grew 11% and international revenue grew 26% on a reported basis and 17% on an organic 1 basis,”
Jacob S. Leach changed role as President and Chief Operating Officer at DEXCOM INC.
“On May 9, 2025, Jacob S. Leach was promoted to President and Chief Operating Officer of DexCom, Inc. (the “Company”) effective immediately.”
Karen Dahut resigned as Director at DEXCOM INC.
“On May 1, 2025, Karen Dahut, a director of DexCom, Inc. (the “Company”), resigned from the Board of Directors (the “Board”) of the Company and all committees thereof effective May 8, 2025.”
Renée Galá was appointed as director at DEXCOM INC.
“On March 6, 2025, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom”) increased the size of the Board to eleven directors and appointed Renée Galá as a director effective immediately.”
Earnings Releases
DEXCOM INC reported the quarter ended March 31, 2024 results: revenue $921.0 million, net income $146.4 million, or $0.36 per diluted share, EPS $0.36 per diluted share. Guidance reaffirmed.
“(Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: • Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an organic 1 basis. • U.S. revenue and international revenue both grew 24% on a reported basis and international revenue grew 26% on”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.